MEBO

MEBO Group, a new life science enterprise group that benefits the world, possesses a wealth of global intellectual property assets. It is the founding base of the world-renowned burn and wound regenerative medical technology MEBO/MEBT, the economic leader in realizing the U.S. President's policy of "developing drugs to regenerate damaged organs," the engine of the regenerative life industry chain, and a pioneering company guiding humanity into the new economic world of regenerative life.MEBO Group was established in 1987, originally founded by Dr. Rongxiang Xu and Dr. Li Li as the Beijing Guangming Traditional Chinese Medicine Burn and Wound Research Institute. In 1988, the Moist Exposed Burn Ointment (MEBO) invented by Rongxiang Xu obtained a new drug certificate from China’s Ministry of Health, becoming the first approved new traditional Chinese medicine after the implementation of China's Drug Administration Law in 1984. This drug, along with the Moist Burned and Exposed Therapy (MEBT/MEBO), was one of the ten medical technologies promoted nationwide by the Ministry of Health during the Eighth Five-Year Plan.MEBO Group has two headquarters located in China and the United States, and owns multiple multinational burn, wound, skin regeneration pharmaceutical and medical enterprises in countries such as the United States, China, Thailand, India, and Malaysia. The group has dozens of series of regenerative products with independent intellectual property rights, including medicines, health supplements, nutritional foods, beauty skincare products, and medical devices. In more than 70 countries, over 200,000 doctors across more than 20 fields use MEBO's technologies and products, having treated more than 40 million burn and wound patients, achieving in-situ regenerative restoration of damaged organs such as large-area deep burns, diabetic ulcers, fingertip amputations, open defect wounds, lower limb ulcers, and severe bedsores.MEBO Group holds more than 40 international invention patents in countries and regions such as China, the United States, Europe, and Japan, including core organ regeneration patents like potential regenerative cells and their culture methods, and the repair and regeneration of physiological tissues and functional organs through in vivo and in situ stem cell cultivation. The books authored by MEBO founder Rongxiang Xu, including "Human Body Regenerative Restoration Science," "Burns Regenerative Medicine and Therapy," "Blue Book of Burn Treatment Technology," and "Comprehensive Treatise on Burn Treatment," have all been collected by the U.S. National Library of Medicine. Additionally, the English version of "Burns Regenerative Medicine and Therapy" published by Karger Publishers of Switzerland has been archived by more than a dozen top universities worldwide, including Harvard University, Princeton University, and the Massachusetts Institute of Technology.